hillo logo — Leveraging AI to transform diabetic patient's lives.

hillo

Leveraging AI to transform diabetic patient's lives.

Founded 2016 France France 53 employees Seed Total: $2.10M AI, Health Care +1

General Information

Company Name hillo
Founded Year 2016
Location France France
Employees 53
Industries AI, Health Care, Medical Devices
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with hillo. To contact hillo, visit hillo.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does hillo compare?

A PDF of hillo and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting hillo soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About hillo

hillo is a medtech start-up leveraging AI to transform the lives of diabetic patients. Founded in 2016 and headquartered in France, the company operates in the AI, Health Care, and Medical Devices industries. Noteworthy is their recent €1.30M Seed Round investment on 01 March 2020, with participation from Angels Santé, Wille AG, and NCI Waterstart. This investment demonstrates confidence from industry players in hillo's innovative approach to tackling diabetic care.

Business keywords: AI-powered healthcare, medtech, continuous glucose monitoring, diabetes management, medical services, healthtech, innovation, patient monitoring, digital health, patient-centric solutions

Services & Products

AI-based digital twin technology for precision diabetes care

Target Customers

Healthcare professionals (HCPs) patients with diabetes

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round €1.30M 3
Angels Santé, Wille AG +1
01 Mar 2020
Pre Seed Round €800.00K 4
Angels Santé, Wille AG +2
01 Jun 2018

hillo Alternatives & Competitors

View All Alternatives
hillo vs

At GlySens®, we are dedicated to advancing the care of individuals with diabetes through the develop...

Series D
5 employees
Health Care, Manufacturing
hillo vs

A wearable device for non-invasive measurement of blood glucose concentration using spectrophotometr...

Seed
19 employees
Biotechnology, Hardware
hillo vs
Echo Therapeutics
Echo Therapeutics United States

Echo Therapeutics is developing its non-invasive, wireless, continuous glucose monitoring (CGM) syst...

Post-IPO Debt
8 employees
Biotechnology, Health Care

FAQ About hillo

Leveraging AI to transform diabetic patient's lives.
hillo was founded in 2016.
hillo is headquartered in France.
hillo operates in AI, Health Care and Medical Devices. Its work centres on AI-powered healthcare, medtech, continuous glucose monitoring and diabetes management. Its customers include Healthcare professionals (HCPs) and patients with diabetes.
hillo has approximately 53 employees.
hillo has completed 2 funding rounds, raising a total of $2.10M. The latest funding stage is Seed.
hillo offers: AI-based digital twin technology for precision diabetes care.
Top alternatives and competitors to hillo include GlySens Incorporated, GlucoActive Sp. z o.o., Echo Therapeutics, Senseonics, Incorporated, Medtrum Technologies Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
hillo and GlySens Incorporated are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for hillo, https://bouncewatch.com/company/hillo, updated 28 January 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes